{
    "root": "347c890a-11c0-b771-e063-6394a90a1a4d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metformin Hydrochloride",
    "value": "20250506",
    "ingredients": [
        {
            "name": "POVIDONE K90",
            "code": "RDH86HJV5Z",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "METFORMIN HYDROCHLORIDE",
            "code": "786Z46389E",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6802"
        }
    ],
    "indications": {
        "text": "metformin hydrochloride tablets indicated adjunct diet exercise improve glycemic control adults pediatric patients 10 years age older type 2 diabetes mellitus .",
        "doid_entities": [
            {
                "text": "type 2 diabetes mellitus (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adult metformin hydrochloride tablets : starting dose : 500 mg orally twice day 850 mg day , meals ( 2.1 ) increase dose increments 500 mg weekly 850 mg every 2 weeks , maximum dose 2550 mg per day , given divided doses ( 2.1 ) doses 2000 mg may better tolerated given 3 times day meals ( 2.1 ) pediatric metformin hydrochloride tablets : starting dose : 500 mg orally twice day , meals ( 2.2 ) increase increments 500 mg weekly maximum 2000 mg per day , given divided doses twice daily ( 2.2 ) renal impairment : prior initiation , assess renal function estimated glomerular filtration rate ( egfr ) ( 2.3 ) patients egfr 30 ml/minute/1.73 2 ( 2.3 ) initiation recommended patients egfr 30 45 ml/minute/1.73 2 ( 2.3 ) assess risk/benefit continuing egfr falls 45 ml/minute/1.73 2 ( 2.3 ) discontinue egfr falls 30 ml/minute/1.73 2 ( 2.3 ) discontinuation iodinated contrast imaging procedures : metformin hydrochloride tablets may need discontinued time , prior , iodinated contrast imaging procedures ( 2.4 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "metformin hydrochloride tablets usp , 500 mg : white , biconvex , circular shaped film coated tablets \u2018 \u2019 debossed one side \u2018 12 \u2019 debossed side . ndc : 70518-1149-00 ndc : 70518-1149-01 ndc : 70518-1149-02 packaging : 30 1 blister pack packaging : 100 1 box packaging : 1 1 pouch store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . dispense light-resistant containers . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "metformin hydrochloride tablets contraindicated patients : severe renal impairment ( egfr 30 ml/min/1.73 2 ) [ ( 5.1 ) ] . hypersensitivity metformin . acute chronic metabolic acidosis , including diabetic ketoacidosis , without coma .",
    "indications_original": "Metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.",
    "contraindications_original": "Adult Dosage for Metformin Hydrochloride Tablets: Starting dose: 500 mg orally twice a day or 850 mg once a day, with meals (2.1) Increase the dose in increments of 500 mg weekly or 850 mg every 2 weeks, up to a maximum dose of 2550 mg per day, given in divided doses (2.1) Doses above 2000 mg may be better tolerated given 3 times a day with meals (2.1) Pediatric Dosage for Metformin Hydrochloride Tablets: Starting dose: 500 mg orally twice a day, with meals (2.2) Increase dosage in increments of 500 mg weekly up to a maximum of 2000 mg per day, given in divided doses twice daily (2.2) Renal Impairment: Prior to initiation, assess renal function with estimated glomerular filtration rate (eGFR) (2.3) Do not use in patients with eGFR below 30 mL/minute/1.73 m 2 (2.3) Initiation is not recommended in patients with eGFR between 30 to 45 mL/minute/1.73 m 2 (2.3) Assess risk/benefit of continuing if eGFR falls below 45 mL/minute/1.73 m 2 (2.3) Discontinue if eGFR falls below 30 mL/minute/1.73 m 2 (2.3) Discontinuation for Iodinated Contrast Imaging Procedures: Metformin hydrochloride tablets may need to be discontinued at time of, or prior to, iodinated contrast imaging procedures (2.4)",
    "warningsAndPrecautions_original": "Metformin Hydrochloride Tablets USP, 500 mg:\u00a0White, biconvex, circular shaped film coated tablets with \u2018A\u2019 debossed on one side and \u201812\u2019 debossed on the other side.\n                  \n                  NDC: 70518-1149-00\n                  NDC: 70518-1149-01\n                  NDC: 70518-1149-02\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 100 in 1 BOX\n                  PACKAGING: 1 in 1 POUCH\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  Dispense in light-resistant containers.\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Metformin hydrochloride tablets are contraindicated in patients with:\n                  \n                  \n                     Severe renal impairment (eGFR below 30 mL/min/1.73 m\n  \n   2)\n  \n   [see\n   \n    Warnings and Precautions (5.1)].\n  \n   \n                     \n                     Hypersensitivity to metformin.\n                     Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.",
    "drug": [
        {
            "name": "Metformin Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6802"
        }
    ]
}